Gregory S. Martini's most recent trade in Kyverna Therapeutics Inc. was a trade of 325,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kyverna Therapeutics Inc | Gregory S. Martini | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 325,000 | 325,000 | - | - | Stock Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | Gregory S. Martini | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 136,612 | 297,213 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Gregory S. Martini | Chief Financial Officer | 11 Aug 2025 | 1,265 | 182,545 (0%) | 0% | 0.8 | 1,063 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Gregory S. Martini | Chief Financial Officer | 10 Feb 2025 | 12,052 | 183,810 (0%) | 0% | 1.8 | 21,212 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Gregory S. Martini | Chief Financial Officer | 27 Jan 2025 | 111,111 | 195,862 (0%) | 0% | 0 | Class A Common Stock |